Our experimental research program explores three regenerative medicine modalities — stem cell therapy, peptide protocols, and psychedelic-assisted therapy — with the hypothesis that their combination may produce outcomes no single approach can achieve alone.
Pillar 1 — Cellular Repair
The most direct approach to tinnitus: repair or replace the damaged cochlear hair cells that started the cascade.
Tinnitus typically begins with damage to the cochlear hair cells — the sensory receptors that convert sound waves into neural signals. In mammals, these cells do not spontaneously regenerate. However, recent advances in stem cell biology have identified multiple pathways for potential restoration.
Mesenchymal stem cells (MSCs) and their derived exosomes have shown neuroprotective effects on auditory neurons. Lgr5+ progenitor cells within the cochlea have been identified as potential hair cell precursors. Gene therapy approaches using Atoh1 transcription factor have demonstrated the ability to stimulate new hair cell growth in animal models.
Our investigational approach focuses on intratympanic delivery of MSC-derived exosomes — a minimally invasive method that delivers regenerative factors directly to the cochlea without the risks of systemic stem cell administration.
Hair Cell Regeneration via Lgr5+ Progenitors
McLean et al. (2017) — Cell Reports
Identified Lgr5+ stem cells in the cochlea capable of differentiating into functional hair cells in mouse models.
Cochlear Gene Therapy for Hair Cell Regeneration
Atkinson et al. (2022) — Nature Medicine
Demonstrated Atoh1 gene therapy could stimulate new hair cell growth in damaged cochleae, with partial hearing restoration.
MSC-Derived Exosomes for Auditory Nerve Protection
Warnecke et al. (2021) — Frontiers in Neuroscience
Mesenchymal stem cell exosomes protected auditory neurons from cisplatin-induced damage and promoted regeneration.
Pillar 2 — Nerve Regeneration
BPC-157 and TB-500: investigational peptides with demonstrated neuroprotective and anti-inflammatory properties that may support auditory nerve recovery.
Even if cochlear hair cells could be regenerated, the auditory nerve pathway between ear and brain is often compromised. Chronic neuroinflammation, axonal degeneration, and synaptic damage create a “broken wire” that prevents signals from reaching the auditory cortex properly.
BPC-157 (Body Protective Compound) is a pentadecapeptide derived from gastric juice that has shown remarkable neuroprotective effects in preclinical research. Dr. Predrag Sikiric's lab has published extensively on its ability to promote peripheral nerve healing, reduce inflammation via NO system modulation, and protect neurons from excitotoxic damage.
TB-500 (Thymosin Beta-4) promotes angiogenesis, reduces inflammatory cytokines, and accelerates tissue repair. Applied to the auditory system, these peptides may help restore the neural infrastructure needed for proper signal transmission — reducing the aberrant neural activity that manifests as tinnitus.
BPC-157 Neuroprotective Effects
Sikiric et al. (2023) — Current Pharmaceutical Design
BPC-157 demonstrated significant neuroprotective and neuroregenerative properties, including peripheral nerve repair and anti-inflammatory action via NO system modulation.
TB-500 in Nerve Regeneration
Sosne et al. (2020) — Expert Opinion on Biological Therapy
Thymosin Beta-4 promoted nerve regeneration and reduced inflammation through upregulation of anti-inflammatory cytokines and angiogenesis.
Peptide-Based Cochlear Protection
Rybak & Ramkumar (2022) — Hearing Research
Targeted peptide therapies showed promise in protecting cochlear structures from noise-induced and ototoxic damage.
Pillar 3 — Neural Rewiring
Psilocybin promotes neuroplasticity — the brain's ability to form new connections. If tinnitus is a disorder of maladaptive plasticity, psychedelics may help rewire the circuit.
Modern neuroscience increasingly understands tinnitus as a disorder of maladaptive neural plasticity. When cochlear input is lost, the auditory cortex doesn't simply go quiet — it reorganizes, amplifying spontaneous neural activity into the phantom perception of sound.
Psilocybin, the active compound in certain mushroom species, has been shown to profoundly increase neural plasticity. Research from Johns Hopkins Center for Psychedelic and Consciousness Research demonstrates that psilocybin increases dendritic spine density, promotes synaptogenesis, and reduces activity in the default mode network — the brain region associated with rumination and self-referential thought.
Our exploratory hypothesis: administered in a controlled therapeutic setting with integration support, psilocybin-assisted therapy may help the auditory cortex form new, healthy patterns of activity — overwriting the maladaptive circuits that generate the phantom tinnitus signal. This would represent a fundamentally new approach: not masking the sound, but helping the brain stop creating it.
Psilocybin and Neural Plasticity
Ly et al. (2018) — Cell Reports
Psilocybin promoted structural and functional neural plasticity — increased dendritic spine density and synaptogenesis in cortical neurons.
Psilocybin for Treatment-Resistant Depression
Carhart-Harris et al. (2021) — New England Journal of Medicine
Psilocybin therapy was as effective as escitalopram for depression, with evidence of increased brain connectivity and reduced default mode network activity.
Auditory Cortex Plasticity and Tinnitus
Shore et al. (2022) — Nature Reviews Neuroscience
Demonstrated that tinnitus involves maladaptive plasticity in the auditory cortex — cross-modal changes that could theoretically be reversed through targeted neuroplasticity interventions.
The Core Hypothesis
Each modality addresses a different layer of the tinnitus mechanism. Together, they may create a synergistic therapeutic effect that no single approach can achieve.
Layer 1: Hardware
Stem cells restore cochlear hair cells — the biological transducers that convert sound to neural signal.
Layer 2: Wiring
Peptides reduce neuroinflammation and promote auditory nerve regeneration — restoring signal integrity.
Layer 3: Software
Psychedelics promote neuroplasticity — helping the brain rewire maladaptive circuits and stop generating phantom sound.
Stem cells provide the raw biological material. Peptides create the optimal regenerative environment. Psychedelics open a window of neuroplasticity during which the brain can integrate restored sensory input. The sequencing and timing of these interventions may be as important as the interventions themselves — and this is precisely what our proposed pilot study is designed to investigate.
Proposed Investigation
An exploratory, open-label pilot study to evaluate the safety and preliminary efficacy of combination regenerative therapy for chronic tinnitus.
Study Type
Open-label exploratory pilot
Participants
N = 20-30
Duration
12 weeks active + 6-month follow-up
Estimated Cost
$300,000 - $500,000
Primary Endpoint
Tinnitus Functional Index (TFI) change from baseline
Secondary Endpoints
Audiometric assessment, fMRI auditory cortex activity, quality of life (THI), sleep quality (PSQI)
IRB Partner
Scottsdale Research Institute (DEA Schedule I licensed)
Design
3 treatment arms + combination arm
Intratympanic MSC-derived exosome delivery, 3 treatments over 12 weeks
BPC-157 (250mcg/day) + TB-500 subcutaneous, 12-week course
2 psilocybin sessions (25mg) with integration therapy, weeks 4 and 8
All three interventions, sequenced: stem cells (weeks 1-4), peptides (weeks 1-12), psilocybin (weeks 6, 10)
Weeks 1-4
Baseline + Stem Cell
Weeks 4-8
Peptide + Integration
Weeks 8-12
Full Protocol
Months 4-9
Follow-up
Research Network
Local IRB Partner
DEA Schedule I licensed facility. Clinical trial experience with MDMA and psilocybin. Located in Scottsdale, AZ — our home base.
BPC-157 Research Pioneer
University of Zagreb. Published 100+ papers on BPC-157 including neuroprotection, nerve regeneration, and NO system modulation.
Model & Inspiration
Leading institution for psilocybin research. Their protocols for therapeutic administration inform our study design.
Research Funding Model
Pioneered IP-NFT framework for longevity research funding. Their governance model is a template for our community-driven approach.
Research Ecosystem Partners
Research organizations focused on psychedelic and neurological science. Potential co-funding and knowledge sharing partners.
IP-NFT Infrastructure
Provides the technical infrastructure for tokenizing research IP, enabling community ownership and governance of our research output.
Important Disclaimer
All research described on this page is experimental, investigational, and exploratory. These are not FDA-approved treatments for tinnitus. The proposed pilot study has not yet received IRB approval. Stem cell therapy, peptide protocols, and psychedelic-assisted therapy for tinnitus are in early translational research phases. No claims of efficacy are made. Participation in future clinical trials will require informed consent and medical screening.
Every dollar contributed goes directly toward making this pilot study a reality. Every registry sign-up demonstrates the demand. This is science by the people, for the people.